Cargando…

Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma

Proinflammatory cytokines that are produced by helper T cells (Th) regulate immune reactions, facilitate class switching of B cells, and prolong the lifespan of B and T cells. Eradication therapy using antibiotics is sometimes effective against gastrointestinal (GI) malignant lymphoma, suggesting th...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata-Takata, Tomoko, Takata, Katsuyoshi, Toji, Tomohiro, Goto, Naoe, Kasahara, Senji, Takahashi, Takeshi, Tari, Akira, Noujima-Harada, Mai, Miyata, Takafumi, Sato, Yasuharu, Yoshino, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682061/
https://www.ncbi.nlm.nih.gov/pubmed/26674732
http://dx.doi.org/10.1038/srep18434
_version_ 1782405827315892224
author Miyata-Takata, Tomoko
Takata, Katsuyoshi
Toji, Tomohiro
Goto, Naoe
Kasahara, Senji
Takahashi, Takeshi
Tari, Akira
Noujima-Harada, Mai
Miyata, Takafumi
Sato, Yasuharu
Yoshino, Tadashi
author_facet Miyata-Takata, Tomoko
Takata, Katsuyoshi
Toji, Tomohiro
Goto, Naoe
Kasahara, Senji
Takahashi, Takeshi
Tari, Akira
Noujima-Harada, Mai
Miyata, Takafumi
Sato, Yasuharu
Yoshino, Tadashi
author_sort Miyata-Takata, Tomoko
collection PubMed
description Proinflammatory cytokines that are produced by helper T cells (Th) regulate immune reactions, facilitate class switching of B cells, and prolong the lifespan of B and T cells. Eradication therapy using antibiotics is sometimes effective against gastrointestinal (GI) malignant lymphoma, suggesting that the tumor development or progression is affected by the inflammatory microenvironment. In the present study, serum samples from 148 patients with various subtypes of malignant lymphoma were tested for 11 proinflammatory Th1/Th2 cytokines. In the comparison by subtype or GI lesions, serum interleukin (IL)-8 (P = 6.7E−05), IL-4 (P = 7.5E−05), and IL-1β (P = 0.0043) levels showed significant differences among subtypes, being particularly elevated in follicular lymphomas (FL) and mucosa-associated lymphoid tissue (MALT) lymphomas. Serum IL-8 levels were elevated in GI-FL and MALT lymphomas, and serum IL-4 and IL-1 β levels were elevated in MALT lymphomas. These findings show that GI low-grade B-cell lymphoma could develop against the background of an inflammatory microenvironment. Thus, these cytokines may be useful as diagnostic markers and could provide new insights into tumor development.
format Online
Article
Text
id pubmed-4682061
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46820612015-12-18 Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma Miyata-Takata, Tomoko Takata, Katsuyoshi Toji, Tomohiro Goto, Naoe Kasahara, Senji Takahashi, Takeshi Tari, Akira Noujima-Harada, Mai Miyata, Takafumi Sato, Yasuharu Yoshino, Tadashi Sci Rep Article Proinflammatory cytokines that are produced by helper T cells (Th) regulate immune reactions, facilitate class switching of B cells, and prolong the lifespan of B and T cells. Eradication therapy using antibiotics is sometimes effective against gastrointestinal (GI) malignant lymphoma, suggesting that the tumor development or progression is affected by the inflammatory microenvironment. In the present study, serum samples from 148 patients with various subtypes of malignant lymphoma were tested for 11 proinflammatory Th1/Th2 cytokines. In the comparison by subtype or GI lesions, serum interleukin (IL)-8 (P = 6.7E−05), IL-4 (P = 7.5E−05), and IL-1β (P = 0.0043) levels showed significant differences among subtypes, being particularly elevated in follicular lymphomas (FL) and mucosa-associated lymphoid tissue (MALT) lymphomas. Serum IL-8 levels were elevated in GI-FL and MALT lymphomas, and serum IL-4 and IL-1 β levels were elevated in MALT lymphomas. These findings show that GI low-grade B-cell lymphoma could develop against the background of an inflammatory microenvironment. Thus, these cytokines may be useful as diagnostic markers and could provide new insights into tumor development. Nature Publishing Group 2015-12-17 /pmc/articles/PMC4682061/ /pubmed/26674732 http://dx.doi.org/10.1038/srep18434 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Miyata-Takata, Tomoko
Takata, Katsuyoshi
Toji, Tomohiro
Goto, Naoe
Kasahara, Senji
Takahashi, Takeshi
Tari, Akira
Noujima-Harada, Mai
Miyata, Takafumi
Sato, Yasuharu
Yoshino, Tadashi
Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma
title Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma
title_full Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma
title_fullStr Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma
title_full_unstemmed Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma
title_short Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma
title_sort elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade b-cell lymphoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682061/
https://www.ncbi.nlm.nih.gov/pubmed/26674732
http://dx.doi.org/10.1038/srep18434
work_keys_str_mv AT miyatatakatatomoko elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT takatakatsuyoshi elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT tojitomohiro elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT gotonaoe elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT kasaharasenji elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT takahashitakeshi elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT tariakira elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT noujimaharadamai elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT miyatatakafumi elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT satoyasuharu elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma
AT yoshinotadashi elevationofseruminterleukins84and1blevelsinpatientswithgastrointestinallowgradebcelllymphoma